These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 845001)

  • 1. Measurement of plasma contrast levels during excretory urography.
    Hunter TB; Thornbury JR; Silver TM; Medzihradsky F
    Invest Urol; 1977 Mar; 14(5):378-9. PubMed ID: 845001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple spectrophotometric procedure for the determination of various chontrast media in plasma.
    Medzihradsky F; Dahlstrom PJ; Hunter TB; Thornbury JR; Silver TM
    Invest Radiol; 1975; 10(5):532-5. PubMed ID: 1205713
    [No Abstract]   [Full Text] [Related]  

  • 3. The old and the new: a study of five contrast media for urography.
    Davies P; Panto PN; Buckley J; Richardson RE
    Br J Radiol; 1985 Jul; 58(691):593-7. PubMed ID: 3893610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast and electrolyte dynamics of the intravenous pyelogram. II. Disparities in serum and urine concentrations of meglumine and anion.
    Lasser EC; Lang JH; Hamblin AE; Rosen L
    Invest Radiol; 1975; 10(4):307-13. PubMed ID: 1184320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sodium salts or methylglucamine salts in contrast media for infusion pyelography? (author's transl)].
    Taenzer V; Albrecht A; Clauss W; Held I
    Radiologe; 1981 Jun; 21(6):288-90. PubMed ID: 7022552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of glomerular filtration rate by fluorescent excitation of non-radioactive meglumine iothalamate.
    Guesry P; Kaufman L; Orloff S; Nelson JA; Swann S; Holliday M
    Clin Nephrol; 1975; 3(4):134-8. PubMed ID: 1149336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Excretory urography--current indications of the status of a conventional diagnostic method. Status of nonionic and ionic contrast media].
    Porst H; Mayer R
    Fortschr Med; 1985 Aug; 103(30):755-8. PubMed ID: 4043912
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contrast quality of iopamidol in excretory urography. Comparative clinical evaluation at various imaging times].
    Osterhage HR
    Fortschr Med; 1985 Dec; 103(47-48):1105-6. PubMed ID: 4085957
    [No Abstract]   [Full Text] [Related]  

  • 9. CLINICAL EVALUATION OF SODIUM IOTHALAMATE 66.8 PER CENT (CONRAY-400).
    MARSHALL TR; LING JT; BUCHANAN J
    Am J Roentgenol Radium Ther Nucl Med; 1964 Sep; 92():676-81. PubMed ID: 14217086
    [No Abstract]   [Full Text] [Related]  

  • 10. [Iopamidol (Solutrast) in excretory urography].
    Kürschner HD; Nieland F
    Rontgenpraxis; 1985 Jun; 38(6):214-6. PubMed ID: 4023849
    [No Abstract]   [Full Text] [Related]  

  • 11. NOTE ON INTRAVENOUS PYELOGRAPHY WITH 66.8 PER CENT SODIUM IOTHALAMATE; CONRAY-400, IODINE CONTENT 40 PER CENT.
    STEINBERG I; EVANS JA
    Am J Roentgenol Radium Ther Nucl Med; 1964 Aug; 92():267-9. PubMed ID: 14207569
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and clinical studies of ioglicinate, a new contrast medium for intravenous urography.
    Nagel R; Leistenschneider W; Speck U; Clauss W
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):49-53. PubMed ID: 631971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urographic contrast agents. Comparison of sodium and methylglucamine salts of iothalamate monomer and dimer.
    Benness GT; Glazer M
    Clin Radiol; 1973 Oct; 24(4):445-8. PubMed ID: 4621054
    [No Abstract]   [Full Text] [Related]  

  • 14. Double contrast arthrography of the knee. Comparison between three contrast media.
    Laasonen EM; Lindholm A
    Acta Radiol Diagn (Stockh); 1983; 24(3):225-9. PubMed ID: 6624525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Testing a pure methylglucamin salt of joxitalamin acid for contrast and side effects in angiography (author's transl)].
    Dembski JC
    Rontgenblatter; 1975 Aug; 28(8):348-55. PubMed ID: 1215768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEGLUMINE IOTHALAMATE 60 PER CENT AND SODIUM DIATRIZOATE 50 PER CENT. COMPARISON OF UROGRAPHIC QUALITY AND SIDE-EFFECTS.
    DOTTER CT; JUDKINS MP
    Radiology; 1964 Feb; 82():225. PubMed ID: 14115299
    [No Abstract]   [Full Text] [Related]  

  • 17. Double blind comparison of ioglicate and iothalamate in intravenous urography.
    Baitsch T; Beduhn D; Klink G
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():143-7. PubMed ID: 6139069
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of blood-brain barrier disruption in the rabbit following intracarotid iopamidol and methylglucamine iothalamate.
    Wycherley AG; Wilcox J; Sage MR
    Australas Radiol; 1984 Nov; 28(4):294-6. PubMed ID: 6535564
    [No Abstract]   [Full Text] [Related]  

  • 19. A simple method for the identification and assay of iopamidol and iothalamate meglumine in pharmaceutical samples based on proton nuclear magnetic resonance spectroscopy.
    Hanna GM; Lau-Cam CA
    Pharmazie; 2001 Feb; 56(2):152-5. PubMed ID: 11234344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urographic effect and methods of elimination of tri-iodated contrast medium (methylglucamine iothalamate)].
    Ventura M; Arena GC; Comoglio A
    Minerva Radiol; 1966; 11(1):89-96. PubMed ID: 5909347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.